### Evidence Statement CG15AdultES108
Co ntinuous subcutaneous insulin infusion (CSII) improves nocturnal and morning glycaemic co ntrol compared with multiple daily injection (MDI) regimens. With multiple injection re g imens the morning injection must not be delaye d. Total and bolus insulin doses required are lower with CSII compared with MDI 130



[@Haakens_1989]
